View of INSULYSIN INHIBITORS AS NOVEL ANTI-DIABETIC AGENTS: FROM COMPUTATIONAL DESIGN TO PRE-CLINICAL VALIDATION

Return to Article Details INSULYSIN INHIBITORS AS NOVEL ANTI-DIABETIC AGENTS: FROM COMPUTATIONAL DESIGN TO PRE-CLINICAL VALIDATION Download Download PDF